Wednesday, February 21, 2024
Canada’s Politics and Government News Source Since 1989
Wednesday, February 21, 2024 | Latest Paper

Nigel Rawson

Opinion | BY NIGEL RAWSON, JOHN ADAMS | November 15, 2023
If Canadians are not to endure further wait times and denials of access to innovative medicines, our governments need to change their antipathy towards the biopharmaceutical industry, write Nigel Rawson and John Adams. Image courtesy of Pixabay
Opinion | BY NIGEL RAWSON, JOHN ADAMS | November 15, 2023
Opinion | BY NIGEL RAWSON, JOHN ADAMS | November 15, 2023
If Canadians are not to endure further wait times and denials of access to innovative medicines, our governments need to change their antipathy towards the biopharmaceutical industry, write Nigel Rawson and John Adams. Image courtesy of Pixabay
Opinion | BY NIGEL RAWSON | June 26, 2023
Canadians with unmet health-care needs whose quality of life or longevity depends on access to new innovative medicines are the losers in this debacle, writes Nigel Rawson. Unsplash photograph by Towfiqu Barbhuiya
Opinion | BY NIGEL RAWSON | June 26, 2023
Opinion | BY NIGEL RAWSON | June 26, 2023
Canadians with unmet health-care needs whose quality of life or longevity depends on access to new innovative medicines are the losers in this debacle, writes Nigel Rawson. Unsplash photograph by Towfiqu Barbhuiya
Opinion | BY NIGEL RAWSON | June 9, 2019
If importation of drugs into America from Canada were to proceed unchecked, Canadian prices would rise, writes Nigel Rawson. Photograph courtesy of Pixabay
Opinion | BY NIGEL RAWSON | June 9, 2019
Opinion | BY NIGEL RAWSON | June 9, 2019
If importation of drugs into America from Canada were to proceed unchecked, Canadian prices would rise, writes Nigel Rawson. Photograph courtesy of Pixabay